Answers are grounded in this paper and cite their sources.
The association of myopathy with epsilon-aminocaproic acid (EACA) treatment after subarachnoid hemorrhage in two cases is reported. Clinical and laboratory findings and possible mechanisms are discussed in light of the known pharmacology of the drug. Recovery ensues if EACA treatment is terminated as soon as myopathy appears.
No takes yet. Share an insight, caveat, or question.
MacKay et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: